Promising Results for Erenumab in Treating Episodic Migraine, shows APPRAISE Trial
In a novel trial, researchers have found that erenumab may be a more effective and tolerable option for patients with episodic migraine who have not responded well to previous oral migraine preventive medications (OMPMs). The findings, published in a recent issue of a prestigious medical journal, shed light on the potential benefits of early intervention […]